A blended-style equity fund seeking long-term growth by employing a sector-centric approach.
Is this fund right for you?
- You want your money to grow over a longer term.
- You want to invest in equities outside of Canada and the U.S.
- You're comfortable with a moderate level of risk.
Risk Rating
How is the fund invested?
(as of August 31, 2025)
Asset allocation (%)
|
Name |
Percent |
|
International Equity |
94.3 |
|
Cash and Equivalents |
4.8 |
|
Canadian Equity |
0.9 |
Geographic allocation (%)
|
Name |
Percent |
|
United Kingdom |
20.2 |
|
Japan |
18.9 |
|
France |
10.5 |
|
Netherlands |
9.2 |
|
Switzerland |
6.0 |
|
Germany |
5.2 |
|
Italy |
4.9 |
|
Ireland |
4.3 |
|
United States |
4.0 |
|
Other |
16.8 |
Sector allocation (%)
|
Name |
Percent |
|
Financial Services |
20.4 |
|
Industrial Goods |
14.7 |
|
Healthcare |
11.2 |
|
Consumer Goods |
10.9 |
|
Technology |
8.5 |
|
Consumer Services |
6.9 |
|
Utilities |
5.5 |
|
Cash and Cash Equivalent |
4.8 |
|
Basic Materials |
4.5 |
|
Other |
12.6 |
Growth of $10,000
(since inception)
Data not available based on date of inception
Fund details
(as of August 31, 2025)
Top holdings |
% |
Federal Home Loan 0.00% 01-Sep-2025 |
3.8 |
Iberdrola SA |
3.0 |
Hoya Corp |
2.7 |
Mitsubishi UFJ Financial Group Inc |
2.6 |
Roche Holding AG - Partcptn |
2.4 |
Sony Group Corp |
2.4 |
Nintendo Co Ltd |
2.4 |
Airbus SE |
2.4 |
ASML Holding NV |
2.3 |
AstraZeneca PLC |
2.3 |
Total allocation in top holdings |
26.3 |
Portfolio characteristics |
|
Standard deviation |
11.3% |
Dividend yield |
2.3% |
Average market cap (million) |
$183,191.6 |
Understanding returns
Annual compound returns (%)
1 MO |
3 MO |
YTD |
1 YR |
{{snapShot.Return1Mth|customNumber:1}} | {{snapShot.Return3Mth|customNumber:1}} | {{snapShot.ReturnYTD|customNumber:1}} | {{snapShot.Return1Yr|customNumber:1}} |
3 YR |
5 YR |
10 YR |
INCEPTION |
{{snapShot.Return3Yr|customNumber:1}} | {{snapShot.Return5Yr|customNumber:1}} | {{snapShot.Return10Yr|customNumber:1}} | {{snapShot.ReturnInception|customNumber:1}} |
Calendar year returns (%)
2024 |
2023 |
2022 |
2021 |
{{snapShot.Return1YrCalendar|customNumber:1}} | {{snapShot.Return2YrCalendar|customNumber:1}} | {{snapShot.Return3YrCalendar|customNumber:1}} | {{snapShot.Return4YrCalendar|customNumber:1}} |
2020 |
2019 |
2018 |
2017 |
{{snapShot.Return5YrCalendar|customNumber:1}} | {{snapShot.Return6YrCalendar|customNumber:1}} | {{snapShot.Return7YrCalendar|customNumber:1}} | {{snapShot.Return8YrCalendar|customNumber:1}} |
Range of returns over five years
(February 1, 2015 - August 31, 2025)
Best return |
Best period end date |
Worst return |
Worst period end date |
9.4% |
March 2025 |
-2.5% |
Oct. 2022 |
Average return |
% of periods with positive returns |
Number of positive periods |
Number of negative periods |
3.3% |
79.4% |
54 |
14 |
Q2 2025 Fund Commentary
Market commentary
Global equity markets were volatile following the U.S. administration’s April announcement of tariffs on nearly all imports. However, global trade tensions eased after the U.S. administration delayed putting the planned tariff hikes in place, reducing investor fears of a global recession. Investors remained concerned about elevated inflation in certain regions, but reduced recession fears improved consumer sentiment. Non-U.S. equity markets rose for the quarter, with emerging market equities outperforming developed market equities and international growth stocks outperforming value stocks.
The onset of the Israel-Iran conflict in mid-June and its ceasefire at month-end had minimal impact on global equity markets. Investors largely looked through the risks, although oil price volatility rose because of concerns that a broadening of the conflict could have uneven impacts globally.
Performance
The Fund’s relative exposure to Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC) and JD Sports Fashion PLC was positive for performance. TSMC benefited from its competitive advantage related to its technologies and innovations and its business track record. JD Sports Fashion stock rose based on its growing U.S. and European presence.
Relative exposure to BP PLC and ICON PLC was negative for the Fund’s performance. BP stock fell after it reported disappointing first-quarter results driven by weak gas trading. ICON underperformed after it reported weaker-than-expected first-quarter results and lowered its full-year forecast. The company cited delays and cancellations in clinical trial activity, particularly among biotech clients, highlighting ongoing softness in the contract research market.
At the sector level, stock selection in information technology and industrials was positive for the Fund’s performance. Underweight exposure to consumer discretionary was positive for performance. Overweight exposure and stock selection in energy and health care was negative for the Fund’s performance.
At the regional level, stock selection in Japan was positive for the Fund’s performance. Overweight exposure and stock selection in Europe was negative for performance. This was mainly because of holdings in France, Ireland and the U.K.
Portfolio activity
The sub-advisor added Akzo Nobel NV, Vinci SA and SSE PLC to the Fund. Akzo Nobel was purchased as its management restructures to reduce costs and improve returns. Vinci offered high-quality infrastructure assets, a strong third-party contracting business and a discounted valuation. SSE was added because its contracts are inflation-linked, and the sub-advisor believes its profitable growth will continue, largely driven by network and renewable power investments.
Existing holdings in AstraZeneca PLC and ICON were increased. Hitachi Ltd. was sold after strong performance. Shinhan Financial Group Co. Ltd., HSBC Holdings PLC and SBM Offshore NV were also sold. The sub-advisor reduced holdings in Smith & Nephew PLC and NXP Semiconductors NV.
Outlook
There was no change to the sub-advisor’s investment approach during the quarter. Bottom-up stock selection continues to drive the sub-advisor’s investment decisions.